🇺🇸 FDA
Patent

US 12240914

Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 12240914 (Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof) held by MAB-LEGEND BIOTECH CO., LTD. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MAB-LEGEND BIOTECH CO., LTD.
Grant date
Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61P, A61P7/02